Retention rate and predictor factors of drug discontinuation in axial spondyloarthritis: a focus on certolizumab and secukinumab

ATALAR E., Konak H. E., AKYÜZ DAĞLI P., ÖZDEMİR ULUSOY B., KARAKAŞ Ö., ORHAN K., ...More

Reumatismo, 2025 (Peer-Reviewed Journal)